| Th17 cells in cancer: the ultimate identity crisis SR Bailey, MH Nelson, RA Himes, Z Li, S Mehrotra, CM Paulos Frontiers in immunology 5, 276, 2014 | 352 | 2014 |
| Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides HM Moulton, MH Nelson, SA Hatlevig, MT Reddy, PL Iversen Bioconjugate chemistry 15 (2), 290-299, 2004 | 285 | 2004 |
| Platelets subvert T cell immunity against cancer via GARP-TGFβ axis S Rachidi, A Metelli, B Riesenberg, BX Wu, MH Nelson, C Wallace, ... Science Immunology 2 (11), eaai7911, 2017 | 224 | 2017 |
| Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity RP Wu, DS Youngblood, JN Hassinger, CE Lovejoy, MH Nelson, ... Nucleic acids research 35 (15), 5182-5191, 2007 | 161 | 2007 |
| Compositions for enhancing transport of molecules into cells PL Iversen, HM Moulton, MH Nelson, AD Kroeker, DA Stein US Patent 7,468,418, 2008 | 143 | 2008 |
| Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity MH Nelson, DA Stein, AD Kroeker, SA Hatlevig, PL Iversen, HM Moulton Bioconjugate chemistry 16 (4), 959-966, 2005 | 106 | 2005 |
| Vaccination with poly (IC: LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer S Mehrotra, CD Britten, S Chin, E Garrett-Mayer, CA Cloud, M Li, G Scurti, ... Journal of hematology & oncology 10 (1), 1-13, 2017 | 102 | 2017 |
| RNA repair restores hemoglobin expression in IVS2–654 thalassemic mice S Svasti, T Suwanmanee, S Fucharoen, HM Moulton, MH Nelson, ... Proceedings of the National Academy of Sciences 106 (4), 1205-1210, 2009 | 101 | 2009 |
| Compositions for enhancing transport of molecules into cells PL Iversen, HM Moulton, MH Nelson, AD Kroeker, DA Stein US Patent 9,572,899, 2017 | 93 | 2017 |
| Harnessing the microbiome to enhance cancer immunotherapy MH Nelson, MA Diven, LW Huff, CM Paulos Journal of immunology research 2015, 2015 | 90 | 2015 |
| PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8+ T Cells JS Bowers, K Majchrzak, MH Nelson, BA Aksoy, MM Wyatt, AS Smith, ... Frontiers in immunology 8, 1221, 2017 | 65 | 2017 |
| Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence SR Bailey, MH Nelson, K Majchrzak, JS Bowers, MM Wyatt, AS Smith, ... Nature communications 8 (1), 1961, 2017 | 64 | 2017 |
| Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion JS Bowers, MH Nelson, K Majchrzak, SR Bailey, B Rohrer, ADM Kaiser, ... JCI insight 2 (5), 2017 | 54 | 2017 |
| Novel immunotherapies for hematologic malignancies MH Nelson, CM Paulos Immunological reviews 263 (1), 90-105, 2015 | 51 | 2015 |
| The inducible costimulator augments Tc17 cell responses to self and tumor tissue MH Nelson, S Kundimi, JS Bowers, CE Rogers, LW Huff, KM Schwartz, ... The Journal of Immunology 194 (4), 1737-1747, 2015 | 50 | 2015 |
| The basics of artificial antigen presenting cells in T cell-based cancer immunotherapies LR Neal, SR Bailey, MM Wyatt, JS Bowers, K Majchrzak, MH Nelson, ... Journal of immunology research and therapy 2 (1), 68, 2017 | 48 | 2017 |
| β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity K Majchrzak, MH Nelson, JS Bowers, SR Bailey, MM Wyatt, JM Wrangle, ... JCI insight 2 (8), 2017 | 37 | 2017 |
| Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic K Majchrzak, MH Nelson, SR Bailey, JS Bowers, XZ Yu, MP Rubinstein, ... Cancer Immunology, Immunotherapy 65, 247-259, 2016 | 36 | 2016 |
| Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 SignalingTBI-Induced IL12 Augments … JS Bowers, MH Nelson, S Kundimi, SR Bailey, LW Huff, KM Schwartz, ... Clinical Cancer Research 21 (11), 2546-2557, 2015 | 34 | 2015 |
| Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning MH Nelson, JS Bowers, SR Bailey, MA Diven, CW Fugle, ADM Kaiser, ... Journal for immunotherapy of cancer 4 (1), 1-14, 2016 | 27 | 2016 |
